[Molecular mechanisms in the development and progression of pancreas and biliary tract cancers]
- PMID: 17233433
[Molecular mechanisms in the development and progression of pancreas and biliary tract cancers]
Abstract
Pancreatic and biliary tract cancers are the most lethal malignancies in the gastrointestinal tract. Investigators have actively investigated to elucidate molecular mechanisms involved in the carcinogenesis, growth, invasion and metastasis of these cancers. This review describes those molecular mechanisms and their correlation with clinicopathological features of pancreatic and biliary tract cancers. Furthermore, recent experimental developments in the gene therapy technologies toward these cancers are also summarized.
Similar articles
-
Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas.Cancer Res. 1998 Dec 1;58(23):5329-32. Cancer Res. 1998. PMID: 9850059
-
Molecular pathology of biliary tract cancers.Cancer Lett. 2007 Jun 8;250(2):155-67. doi: 10.1016/j.canlet.2006.09.011. Epub 2006 Oct 27. Cancer Lett. 2007. PMID: 17069969 Review.
-
Aberrant promoter hypermethylation in biliary tract carcinoma.J Hepatobiliary Pancreat Surg. 2006;13(4):296-305. doi: 10.1007/s00534-005-1058-0. J Hepatobiliary Pancreat Surg. 2006. PMID: 16858540 Review.
-
Loss of Stk11/Lkb1 expression in pancreatic and biliary neoplasms.Mod Pathol. 2003 Jul;16(7):686-91. doi: 10.1097/01.MP.0000075645.97329.86. Mod Pathol. 2003. PMID: 12861065
-
Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.Genes Chromosomes Cancer. 2000 Apr;27(4):353-7. Genes Chromosomes Cancer. 2000. PMID: 10719364
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical